Holocene Advisors
PRVA icon

Holocene Advisors’s Privia Health PRVA Stock Holding History

Holocene Advisors’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Buy
74,391
+62,981
+552% +$1.42M ﹤0.01% 615
2025
Q4 		$271K Sell
11,410
-14,618
-56% -$356K ﹤0.01% 706
2025
Q3 		$648K Buy
+26,028
New +$560K ﹤0.01% 665
2024
Q4 		– Sell
-23,799
Closed -$433K – 856
2024
Q3 		$433K Sell
23,799
-79,819
-77% -$1.52M ﹤0.01% 673
2024
Q2 		$1.8M Sell
103,618
-7,128
-6% -$126K 0.01% 540
2024
Q1 		$2.17M Buy
110,746
+30,143
+37% +$637K 0.01% 567
2023
Q4 		$1.86M Hold
80,603
– – 0.01% 542
2023
Q3 		$1.85M Buy
+80,603
New +$2.05M 0.01% 574
2022
Q2 		– Sell
-78,410
Closed -$2.1M – 965
2022
Q1 		$2.1M Buy
78,410
+34,760
+80% +$821K 0.01% 497
2021
Q4 		$1.13M Buy
43,650
+23,297
+114% +$581K 0.01% 659
2021
Q3 		$480K Buy
+20,353
New +$711K ﹤0.01% 749

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Holocene Advisors's PRVA Position: Q1 2026 in Review

Holocene Advisors increased its Privia Health (PRVA) stake by 552% in Q1 2026, buying an estimated $1.42M and bringing the position to 74,391 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #615.

Holocene Advisors first reported a position in PRVA in Q3 2021 and has held it in 11 quarters since. The position peaked at $2.17M in Q1 2024. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Holocene Advisors held 74,391 shares of Privia Health worth $1.53M as of Q1 2026.
  • Holocene Advisors bought 62,981 Privia Health shares in Q1 2026, an estimated $1.42M.
  • Privia Health made up ﹤0.01% of Holocene Advisors's portfolio in Q1 2026, its #615 holding.
  • Holocene Advisors first reported a position in Privia Health in Q3 2021 and has held it in 11 quarters since.
  • Holocene Advisors's Privia Health position peaked at $2.17M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.